BIOHABIT LTD
Company number 12324549 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£165,594
Balance sheet as at 2025-11-30
What it does
The company is actively involved in research and development, including clinical studies andlaboratory work, to create a non-invasive diagnostic test for early-stage heart failure.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-11-20
- Employees
- 0 (2025 accounts · was 1 in 2024)
- Registered office
- 22 Cherry Vale, Liverpool, England, L25 5PX
- Postcode
- L25 5PX
- Capital
- 100 GBP
- Accounts category
- Micro
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-11-30
- Next due by
- 2027-08-31
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2025-11-19
- Next due by
- 2026-12-03
Nature of business (SIC)
- 32500 Manufacture of medical and dental instruments and supplies
- 72110 Research and experimental development on biotechnology
Officers 2 current
Contact details
- Website
- biohabit.co.uk
Biohabit’s NT-proCheck uses oral fluid for faster, non-invasive heart failure diagnosis, improving outcomes and reducing costs.
Competitors Liverpool
This company ranks 22 among manufacture of medical and dental instruments and supplies in Liverpool.
The class of 2019
40%
of the 286 companies in this sector incorporated in 2019 are still active today; 54% have since been dissolved.
A fact about the year, not a forecast for this company.